Journal of Tropical Oceanography

    Next Articles

γ-Aromatic butenolides lignans from soft coral-associated symbiotic and epiphytic fungi Aspergillus terreus EGF7-0-1 (I)

HE Yueming1#, ZHAO Lining2#, CHEN Xinqi1, HE Jiahong1, FAN Hao1, CHEN Leyi1, ZHANG Cuixain1, HE Xixin1   

  1. 1. School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, P. R. China;

    2. Library, Guangzhou University of Chinese Medicine, Guangzhou 510006, P. R. China

  • Received:2024-03-05 Revised:2024-03-22 Accepted:2024-04-02
  • Contact: ZHANG, Cuixain
  • Supported by:

    National Natural Science Foundation of China (82273845); Special fund of Guangdong Provincial Department of Natural Resources (GDNRC[2023]37, GDNRC[2020]039, GDNRC[2021]048); Innovation and Entrepreneurship Program for College Students in Guangdong Province(202310572224, 202310572291)

Abstract: Tyrosyl-DNA phosphodiesterase 1 (TDP1) is currently recognized as a potential target for cancer treatment. However, no related drugs have been marketed or reported in clinical research. In order to discover potential TDP1 inhibitors, the soft coral-associated symbiotic and epiphytic fungi Aspergillus terreus EGF7-0-1 were fermented with rice media. The secondary metabolites were isolated with the various chromatography technologies (such as TLC, CC, HPLC, etc.) to afford eight γ-aromatic butenolide lignans. Based on NMR, HR-ESI-MS, OR and compare with the literature, their structures were determined as butyrolactones I~V (1~5), aspernolide E (6), asperteretal D (7) and terrusnolide A (8). In this study, the inhibitory activity of these compounds against tyrosyl -DNA phosphodiesterase 1 (TDP1) in vitro was studied for the first time, but it was unfortunate that compounds 1~8 did not show any inhibitory abilities against TDP1. This study provides theoretical data for the discovery of TDP1 inhibitors.

Key words: traditional marine Chinese medicine soft coral, Aspergillus terreus, γ-aromatic butenolides lignans, structural identification, TDP1 inhibitors